Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore

Singapore Med J. 2022 Dec;63(12):759-762. doi: 10.11622/smedj.2021082. Epub 2021 Jun 18.
No abstract available

MeSH terms

  • COVID-19*
  • Humans
  • Immunosuppression Therapy
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation*
  • SARS-CoV-2
  • Singapore
  • Transplant Recipients

Substances

  • Immunosuppressive Agents